Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Post neoadjuvant HER2 treatmen...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Post neoadjuvant HER2 treatment: real world data from a multicentric cohort

Post neoadjuvant HER2 treatment: real world data from a multicentric cohort

Bibliographic Details
Main Authors: P. Luz, I. Fernandes, R. Diaz Acedo, S. Gamez Casado, E. Campoa, L. Alves, A.J. Arede, I. Lomares, J. Baena Cañada, J. Magalhães, A. Fernandes, J.G. Costa, B. Gosalbez
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621000990
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S0960977621000990

Similar Items

  • The evaluation of tumor-infiltrating lymphocytes (TILs) in early breast cancer: differences between histologic subtypes in a Portuguese cohort
    by: P. Luz, et al.
    Published: (2021-04-01)
  • Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study
    by: Jing Peng, et al.
    Published: (2024-03-01)
  • Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancer
    by: Zheng-Jun Yang, et al.
    Published: (2024-01-01)
  • Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer
    by: J. Lluch-Gómez, et al.
    Published: (2023-05-01)
  • Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy
    by: Roberto J. Arai, et al.
    Published: (2018-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs